Jeff Yass’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.25M Buy
+118,794
New +$2.13M ﹤0.01% 6013
2026
Q2
– Sell
-13,428
Closed -$160K – 14843
2026
Q1
$135K Sell
13,428
-1,405
-9% -$20.8K ﹤0.01% 12118
2025
Q4
$452K Buy
+14,833
New +$396K ﹤0.01% 9031
2025
Q3
– Sell
-15,516
Closed -$226K – 14276
2025
Q2
$226K Sell
15,516
-388
-2% -$5.49K ﹤0.01% 10956
2025
Q1
$195K Buy
+15,904
New +$297K ﹤0.01% 10957

Other funds holding BBNX

Jeff Yass's BBNX Position: Q3 2026 in Review

Jeff Yass opened a new position in Beta Bionics (BBNX) in Q3 2026: 118,794 shares worth $2.25M. The stake represents ﹤0.01% of the portfolio and ranks #6013 among its holdings. This is a return to the name: Jeff Yass previously reported a position in BBNX as recently as Q1 2026.

Jeff Yass first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Jeff Yass held 118,794 shares of Beta Bionics worth $2.25M as of Q3 2026.
  • Beta Bionics was a new Jeff Yass position in Q3 2026.
  • Beta Bionics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6013 holding.
  • Jeff Yass first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • 153 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.